Literature DB >> 32065646

Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis.

Yu Zuo1, Lifang Ye1,2, Min Liu3, Shanshan Li1, Weifang Liu3, Fang Chen1, Xin Lu1, Patrick Gordon4, Guochun Wang1,2, Xiaoming Shu1.   

Abstract

OBJECTIVES: To evaluate the distribution of radiological characteristics stratified by different myositis-specific autoantibodies, identify prognostic value of high-resolution CT (HRCT) patterns in DM-associated interstitial lung disease (DM-ILD), and explore the possible mechanism associated with macrophage activation.
METHODS: We enrolled 165 patients with PM/DM-ILD. The distribution of HRCT radiological types with different myositis-specific autoantibodies and the relationship between radiological features and ILD course and prognosis were analysed. Additionally, the potential role of macrophage activation in rapidly progressive ILD (RP-ILD) with DM was studied.
RESULTS: The organizing pneumonia pattern was dominant in HRCT findings of patients with DM-ILD, especially those with anti-SAE (6/6, 100%) and anti-MDA5 (46/62, 74.2%) antibodies. The ratios of organizing pneumonia and nonspecific interstitial pneumonia patterns were almost equal in patients with aminoacyl tRNA synthetase antibodies, and nonspecific interstitial pneumonia pattern was associated with a mild clinical course. Lower lung zone consolidation in HRCT was related to RP-ILD in both anti-MDA5 and anti-aminoacyl tRNA synthetase antibody-positive groups. Ferritin levels of >1000 ng/ml (odds ratio (OR), 12.3; P=0.009), elevated carcinoembryonic antigen (OR, 5.8; P=0.046) and carbohydrate antigen 19-9 (OR, 7.8; P=0.018) were independent predictors of a lower lung zone consolidation pattern in anti-MDA5 antibody-positive DM. The infiltration of CD163-positive macrophages into alveolar spaces was significantly higher in the DM-RP-ILD group than in the chronic DM-ILD group.
CONCLUSION: HRCT patterns are different among variable myositis-specific autoantibodies positive patients with ILD and lower zone consolidation in HRCT correlated with RP-ILD in DM. Activated macrophages may contribute to the pathogenesis of RP-ILD in DM.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  dermatomyositis; interstitial lung disease; lower lung zone consolidation; macrophage activation

Mesh:

Substances:

Year:  2020        PMID: 32065646     DOI: 10.1093/rheumatology/keaa034

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

1.  A New Predictive Model for the Prognosis of MDA5+ DM-ILD.

Authors:  Qian Niu; Li-Qin Zhao; Wan-Li Ma; Liang Xiong; Xiao-Rong Wang; Xin-Liang He; Fan Yu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

2.  Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation.

Authors:  Masaharu Tamaki; Shimpei Matsumi; Hideki Nakasone; Yuhei Nakamura; Masakatsu Kawamura; Shunto Kawamura; Junko Takeshita; Nozomu Yoshino; Yukiko Misaki; Kazuki Yoshimura; Ayumi Gomyo; Aki Tanihara; Yosuke Okada; Machiko Kusuda; Kazuaki Kameda; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Bone Marrow Transplant       Date:  2022-06-04       Impact factor: 5.174

3.  Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.

Authors:  Fang Chen; Jinping Wang; Puli Zhang; Yu Zuo; Lifang Ye; Guochun Wang; Xiaoming Shu
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

4.  Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease.

Authors:  Porntip Intapiboon; Boonjing Siripaitoon
Journal:  Respir Med Case Rep       Date:  2020-11-19

5.  Macrophage activation syndrome as a complication of dermatomyositis: A case report.

Authors:  Ding-Xian Zhu; Jian-Jun Qiao; Hong Fang
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

Review 6.  Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry.

Authors:  Pankti Mehta; Pedro M Machado; Latika Gupta
Journal:  Rheumatol Int       Date:  2021-03-27       Impact factor: 2.631

7.  Aberrantly Expressed Galectin-9 Is Involved in the Immunopathogenesis of Anti-MDA5-Positive Dermatomyositis-Associated Interstitial Lung Disease.

Authors:  Lin Liang; Ya-Mei Zhang; Ya-Wen Shen; Ai-Ping Song; Wen-Li Li; Li-Fang Ye; Xin Lu; Guo-Chun Wang; Qing-Lin Peng
Journal:  Front Cell Dev Biol       Date:  2021-03-25

8.  Clinical Value of 18F-FDG PET/CT Scan and Cytokine Profiles in Secondary Hemophagocytic Lymphohistiocytosis in Idiopathic Inflammatory Myopathy Patients: A Pilot Study.

Authors:  Junyu Liang; Heng Cao; Bowen Wu; Yinuo Liu; Ye He; Bei Xu; Yiduo Sun; Bingjue Ye; Jin Lin
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

Review 9.  Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System.

Authors:  Huifang Hu; Hang Yang; Yi Liu; Bing Yan
Journal:  Front Med (Lausanne)       Date:  2022-01-24

10.  Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.

Authors:  Tamara Vojinovic; Ilaria Cavazzana; Paolo Ceruti; Micaela Fredi; Denise Modina; Marialma Berlendis; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-03       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.